Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Head and Neck Cancer|Lung Cancer|Mesothelioma|Pancreatic Cancer|Prostate Cancer|Sarcoma
Interventions: DRUG: cisplatin|DRUG: pemetrexed disodium|DRUG: sorafenib
Sponsor: Masonic Cancer Center, University of Minnesota